ZENO - Zenosense, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2017
12/30/2016
Total Revenue
0
0
0
Cost of Revenue
-
-
-
Gross Profit
-
-
-
Operating Expenses
Research Development
-
-
0
Selling General and Administrative
149
159
134
Total Operating Expenses
149
159
134
Operating Income or Loss
-149
-159
-134
Interest Expense
237
252
72
Total Other Income/Expenses Net
-99
-155
-43
Income Before Tax
-485
-566
-249
Income Tax Expense
-
-
-
Income from Continuing Operations
-485
-566
-249
Net Income
-485
-566
-249
Net Income available to common shareholders
-485
-566
-249
Reported EPS
Basic
-
-0.03
-0.02
Diluted
-
-0.03
-0.02
Weighted average shares outstanding
Basic
-
21,142
12,564
Diluted
-
21,142
12,564
EBITDA
-
-314
-178